EE311 Evaluating the Cost-Effectiveness of Ruxolitinib for the Treatment of Polycythaemia Vera Patients That Are Resistant/Intolerant to Hydroxycarbamide/Hydroxyurea in England and Wales

• DOI: 10.1016/j.jval.2024.10.593
• Publication Date: 2024-12-25T01:42:08Z
• Authors: R Rafia; L Dunham; A Liu; J Brodie; V Hargreaves; H Skinner; A Nawaz; A Baeza-plaza; D Andrews; H Negi; K Jameson
• Keywords: Polycythaemia; Hydroxycarbamide; Ruxolitinib; Anagrelide